Evidence map›Paper›PMID 39667688›Full record

ReviewJournal of thrombosis and haemostasis : JTH2025

Safe and effective anticoagulation use: case studies in anticoagulation stewardship.

Jori E May, Arthur L Allen, Bethany T Samuelson Bannow, Carlee O'Connor, Katelyn W Sylvester, Scott Kaatz

Abstract readCase ReportsReview
In one paragraph

Review in Journal of thrombosis and haemostasis : JTH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Anticoagulation Stewardship Program in the DOAC Era.Journal of clinical medicine · 2026
    Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jori E MayDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: jemay@uabmc.edu.
Arthur L AllenDepartment of Pharmacy, Veterans Affairs Salt Lake City Health Care System, Salt Lake, Utah, USA. Electronic address: https://twitter.com/AAllenPharmD.
Bethany T Samuelson BannowHemostasis and Thrombosis Center, Oregon Health & Science University, Portland, Oregon, USA; Division of Hematology & Medical Oncology, Department of Medicine at OHSU, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA. Electronic address: https://twitter.com/bsamuelson_md.
Carlee O'ConnorAnticoagulation Services, Mayo Clinic Health System, Eau Claire, Wisconsin, USA.
Katelyn W SylvesterDepartment of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: https://twitter.com/KatelynSylvest4.
Scott KaatzDivision of Hospital Medicine, Henry Ford Health, Detroit, Michigan, USA. Electronic address: https://twitter.com/kaatz_scott.

Funding

Scholars in Women's Health Research Across the LifespanK12HD043488 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MYATT, LESLIE · 2002 to 2023
$10.4M
Oregon BIRCWH: Scholars in Women's Health Research Across the LifespanK12AR084221 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LESLIE MYATT · 2023 to 2026
$2.2M
NIAMS NIH HHS K12 AR084221NICHD NIH HHS K12 HD043488
6 · The paper itself

Abstract

Anticoagulant use is prevalent and associated with significant potential for harm. Anticoagulation stewardship practice has emerged to address care gaps and promote safe, effective, and cost-conscious anticoagulation use across health care systems. We present 4 patient cases describing common challenges in anticoagulation management: inappropriate dosing of direct oral anticoagulants, the diagnosis and management of heparin-induced thrombocytopenia, periprocedural anticoagulation management, and heavy menstrual bleeding on anticoagulation. We discuss available examples of successful stewardship programs that can address the challenges of each case, demonstrating how an investment in anticoagulation stewardship can improve patient outcomes.

Indexed as

AnticoagulantsBlood CoagulationHeparinThrombocytopeniaAdministration, OralAdultAgedFemaleHemorrhageHumansMaleMenorrhagiaMiddle AgedRisk FactorsTreatment OutcomeAnticoagulantsHeparinanticoagulationatrial fibrillationheavy menstrual bleedingischemic strokethrombosis

Identifiers

PMID39667688
PMCPMC11890946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.